Depression Clinical Trials in San Antonio

Showing 141-143 of 143 trials

Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression

NCT00322764

The primary purpose of this study is to determine the safety and efficacy of oral RG2417 (Uridine) when administered to patients with Bipolar I depression twice daily for six weeks.

Bipolar Depression

Repligen Corporation80 participantsStarted Mar 2006

Stanford, California, United States • Smyrna, Georgia, United States • Indianapolis, Indiana, United States +8 more locations

COMPLETEDPhase 3253 miles

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

NCT00035321

The purposes of this study are to determine: * Whether olanzapine plus fluoxetine in combination will help patients with treatment-resistant major depression. * The safety of olanzapine plus fluoxetine in combination, plus and any side effects that might be associated with the combination. * The effectiveness of olanzapine plus fluoxetine compared to olanzapine and fluoxetine alone.

Major Depressive Disorder

Eli Lilly and Company600 participantsStarted Apr 2002

Oceanside, California, United States • San Marcos, California, United States • Torrance, California, United States +30 more locations

Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

Depression Trials in Other Cities

Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response

Other Conditions in San Antonio